JavaScript is not available.

Nov 22, 2022

As the saying goes: the early bird gets the registration! Visit coaconference.com and register by January 31, 2023 to take advantage of the Early Bird Discount for the 2023 COA Conference!

Medicare Advantage plans denied 2M prior authorization requests: analysis

There were more than 35 million prior authorization requests to Medicare Advantage insurers in 2021, according to an analysis from

- from

There were more than 35 million prior authorization requests to Medicare Advantage insurers in 2021, according to an analysis from KFF.

Community oncology groups driving more clinical trials | DDD

Community oncology groups driving more clinical trials - from

@DrugDiscoverDev

drugdiscoverytrends.com

Community oncology groups are poised to conduct a greater share of clinical trials in the coming years, which could help boost diversity.

UnitedHealthcare tried to deny coverage to a chronically ill patient. He fought back, exposing the...

UnitedHealthcare Tried to Deny Coverage to a Chronically Ill Patient. He Fought Back, Exposing the Insurer’s Inner Workings. - from

After a college student finally found a treatment that worked, the insurance giant decided it wouldn’t pay for the costly drugs. His fight to get coverage exposed the insurer’s hidden procedures for...

Federal program forces drug companies to fund hospital profits

"Put simply, in many cases, hospitals buy drugs at basement prices, charge middle-class privately insured patients skyscraper prices, and then pocket the difference." from

@MackinacCenter

@JarrettSkorup

mackinac.org

Program meant to support charity care enriches hospitals

The #COA2023 agenda was designed by community oncologists, for community oncologists. Make sure you're registered for two days of learning and networking on March 23-24! ow.ly/eVPX50MJ48h

Debunking Myths of Clinical Trials for Cancer

COA President Miriam Atkins, MD, FACP, spoke to

@cure_today

to debunk myths surrounding clinical trials in cancer care. Thank you Dr. Atkins!

curetoday.com

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about clinical trials in cancer care.

White House announces new cancer initiatives on Moonshot anniversary

White House announces new cancer initiatives on Moonshot anniversary - from

@axios

@TreedinDC

axios.com

A collection of investments in cancer care and prevention will be announced today by the Biden Administration on the first anniversary of the revived Cancer Moonshot.

FACT SHEET: On One Year Anniversary of Reignited Cancer Moonshot, Biden-Harris Administration...

On One Year Anniversary of Reignited Cancer Moonshot, Biden-⁠Harris Administration Announces New Actions to End Cancer as We Know It - from

@WhiteHouse

whitehouse.gov

One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate

FTC Enforcement Action to Bar GoodRx from Sharing Consumers’ Sensitive Health Info for Advertising

FTC Enforcement Action to Bar GoodRx from Sharing Consumers’ Sensitive Health Info for Advertising - from

@FTC

ftc.gov

The Federal Trade Commission has taken enforcement action for the first time under its Health Breach Notification Rule against the telehealth and prescription drug discount

Consolidated systems charge more for ‘marginally’ better care, study finds

Consolidated systems charge more for ‘marginally’ better care, study finds - from

@healthcaredive

@haileymensik1

healthcaredive.com

Care delivered by physicians in health systems costs between 12% and 26% higher than care delivered by independent physicians, according to a study published in JAMA Network.

Community Oncology Alliance’s Patient Feedback Surveys Reach 200,000 Patient Responses

We're proud to announce that our patient feedback tools have reached 200,000 responses! These tools help practices gather patient feedback and incorporate it into practice improvement.

einpresswire.com

Milestone for Use of Free COA Patient Feedback Tools Closely Follows Release of Condensed Survey, Enabling Patients to Submit Data More Easily

340B: Good Intentions In Need Of Reform | Health Affairs Forefront

"...the #340B program has become gamed by large corporations to increase revenue. It is no longer serving its original intent." from

@Health_Affairs

@DrDiGiorgio

healthaffairs.org

Written in response to Rep. Waxman’s article on 340B published in December 2022 on Forefront. The author argues, “the 340B program has become gamed by large corporations to increase revenue. It is no...

What goes — and what doesn't — with the end of the public health emergency

What goes — and what doesn't — with the end of the public health emergency - from

@axios

@TreedinDC

axios.com

The planned end of the COVID public health emergency on May 11 could cause major disruptions for some health care providers while barely creating a ripple in some major health care industries — at...

Republicans break with another historical ally: doctors

Republicans break with another historical ally: doctors - from

Some Republicans are now openly contemptuous of the AMA.

Hospitals balk at Indiana lawmakers' plan to lower health care costs

Indiana lawmakers on Tuesday said hospitals already had their chance to lower costs, and it’s now the state’s turn - from

@WISH_TV

@GarrettBNews

wishtv.com

INDIANAPOLIS (WISH) -- Indiana lawmakers on Tuesday said hospitals already had their chance to lower costs, and it's now the state's turn. A Republican-backed bill on health care costs targets...

The Year Ahead in Value-Based Care: Trends to Watch as Alternative Payment Models Evolve

The Year Ahead in Value-Based Care: Trends to Watch as Alternative Payment Models Evolve - from

@modrnhealthcr

modernhealthcare.com

In a time of rapid change and growing pressures, several trends will guide the next phase of VBC, shares Jeffrey Scott, MD, chief medical officer of Integra Connect. These include a shift towards...

If you haven't visited coaconference.com to save your spot for #COA2023, there's no better time than now!

Court Rules in Favor of Manufacturers in 340B Contract Pharmacy Case

Court Rules in Favor of Manufacturers in #340B Contract Pharmacy Case - from

@natlawreview

@McDermottLaw

natlawreview.com

Earlier today, the US Court of Appeals for the Third Circuit issued a much-anticipated decision in one of the 340B contract pharmacy cases. The decision is a win for drug manufacturers who have sought

Pharma gets a win in 340B drug discount case

Pharma gets a win in 340B drug discount case - from

Pharmaceutical manufacturers got a victory from the Third Circuit Court of Appeals, with judges ruling providers could not use the 340B drug discount program.

Oregon pharmacists go to battle with benefits managers over drug costs

Pharmacists go to bat for bills that would rein in PBMs in Oregon - from

@PDXBIZJournal

@PDXBIZLiz

bizjournals.com

The bills would enable them to cover the cost of dispensing drugs and prevent more pharmacies from closing, advocates say.

Drug company middlemen likely to be a focus in 118th Congress - Roll Call

"Factions of the health care system and members of Congress are turning their fire on an oft-maligned part of the drug pricing system — the middlemen who negotiate discounts with drug companies on behalf of health plans." from

@rollcall

@jessiehellmann

rollcall.com

PBMs argue that the rebates they collect from drug companies in exchange for coverage by a health plan are used to lower premiums.

We're celebrating the 20th anniversary of COA in the newest COA newsletter! Read more about it, preparing for the EOM, and welcoming a new team member and CPAN co-chair! conta.cc/3XSOatf

Drugmakers prevail in dispute over U.S. discount drug program

Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday - from

@Reuters

@brenpiers

reuters.com

Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday.

COA Applauds Introduction of PBM Investigation and Transparency Bills

Senators reintroduce bills to reform PBM industry - from

Thank you

and

for your leadership and for putting patients ahead of profits. PBMs raise costs and restrict access to needed medications.

communityoncology.org

COA Strongly Supports Bipartisan Pharmacy Benefit Manager Transparency Act (S. 127) and Prescription Pricing for the People Act (S. 113)

Progressing From Disparity to Equity: Untangling the Complexities of Timely Care and the Rural...

Progressing From Disparity to Equity: Untangling the Complexities of Timely Care and the Rural Cancer Experience - from

@CancerNetwrk

cancernetwork.com

Richard L. Martin III, MD, MPH, and Stephen Schleicher, MD, MBA, share a perspective on rural cancer care.

Drug companies brace for chairman Bernie

Sen. Bernie Sanders has long made no secret that he thinks drug companies and health insurers are ripping off Americans. But now he's chairman of the Senate health committee. - from

@axios

@PeterSullivan4

axios.com

Sen. Bernie Sanders has long made no secret that he thinks drug companies and health insurers are ripping off Americans. But now he's chairman of the Senate health committee.

Senators introduced bills to reform PBMs and create new FTC probe

Middlemen Increasingly Block Patient Access to New Generics - from

Two top senators have reintroduced legislation that would introduce several reforms to pharmacy benefit managers, including prohibiting clawbacks of pharmacy payments - from

@FierceHealth

@rking_19

fiercehealthcare.com

Two top senators have reintroduced legislation that would introduce several reforms to pharmacy benefit managers, including prohibiting clawbacks of pharmacy payments. | Two senators reintroduced...

How one bad law drives hospital consolidation and high health care costs

How one bad law drives hospital consolidation and high health care costs - from

@dallasnews

@sallypipes

dallasnews.com

Americans are getting squeezed by rising health care costs. The latest numbers from the Centers for Medicare and Medicaid Services show that patient out-of-pock...

Rev. Al Sharpton calls for stronger Congressional oversight over hospital pharmaceutical program

"This drug discount law, known as “340B” in Beltway jargon, is well intentioned and the right thing to do...Unfortunately, the drug discount program is rife with fraud and benefits from almost no government oversight." from

@afronews

@TheRevAl

afro.com

By Rev. Al Sharpton Over the past year, Democrats in Washington have begun to level the playing field between healthcare special interests like Big Pharma manufacturers and regular Americans,...

Community Oncology Retweeted

are going to do everything possible to push Congress to do something about #PBM abuses. The top PBM oligarchs are the most pronounced entities destroying American health care. This fight doesn't stop! #PBMsMustGo

rollcall.com

Drug company middlemen likely to be a focus in 118th Congress - Roll Call

PBMs argue that the rebates they collect from drug companies in exchange for coverage by a health plan are used to lower premiums.

Reforms needed to make voluminous insurer price data usable: report

Reforms needed to make voluminous insurer price data usable: report - from

@FierceHealth

@rking_19

fiercehealthcare.com

It has been more than six months since insurers were required to release data on their prices, but researchers are finding the long-sought numbers pretty hard to understand. | A new report is asking...

A bellwether for biosimilars: Why the new competition for Humira matters to pharma, payers, and...

A bellwether for biosimilars: Why the new competition for Humira matters to pharma, payers, and patients - from

@statnews

@pharmalot

statnews.com

Governor DeSantis proposes tighter controls on pharmacy benefit managers

Governor DeSantis proposes tighter controls on pharmacy benefit managers - from

@WUWF

@flanigan_tom

wuwf.org

Small independent drug stores say the PBMs put them at a competitive disadvantage.

Hospital price transparency: fines or full compliance?

Hospital price transparency: fines or full compliance? - from

@modrnhealthcr

@alex_kacik

modernhealthcare.com

As of September, 65% of hospitals had posted their negotiated rates with commercial insurers, but some claim full compliance with CMS isn’t worth it.